Can a tiny eye implant tame chronic uveitis Flare-Ups?
NCT ID NCT07423442
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will follow 100 adults with non-infectious posterior uveitis, a chronic inflammatory eye disease, who have received a fluocinolone acetonide implant. Researchers will analyze medical records over three years to see how well the implant reduces the frequency and severity of inflammatory relapses and the need for additional treatments. The goal is to better understand the implant's real-world effectiveness and safety.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- fluocinolone acetonide implant (a corticosteroid implant placed in the eye)
- What this could lead to
- If successful, this study could provide real-world evidence that the fluocinolone implant effectively reduces the number and severity of inflammatory flare-ups in people with chronic uveitis, helping to preserve vision.
- What could go wrong
- This is an observational study, not a controlled trial, so results may be influenced by other treatments or patient differences. The implant is already approved, so this study is about refining its use, not discovering a new cure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NONINFECTIOUS POSTERIOR UVEITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Nantes - Ophthalmology Department
Nantes, Nantes, 44000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.